BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27058291)

  • 1. Negative regulation of the FOXO3a transcription factor by mTORC2 induces a pro-survival response following exposure to ultraviolet-B irradiation.
    Feehan RP; Shantz LM
    Cell Signal; 2016 Aug; 28(8):798-809. PubMed ID: 27058291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of mTORC2 enhances UVB-induced apoptosis in keratinocytes through a mechanism dependent on the FOXO3a transcriptional target NOXA but independent of TRAIL.
    Feehan RP; Nelson AM; Shantz LM
    Cell Signal; 2018 Dec; 52():35-47. PubMed ID: 30172026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lycopene Protects Keratinocytes Against UVB Radiation-Induced Carcinogenesis via Negative Regulation of FOXO3a Through the mTORC2/AKT Signaling Pathway.
    Chen P; Xu S; Qu J
    J Cell Biochem; 2018 Jan; 119(1):366-377. PubMed ID: 28585698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mTOR pathway controls cell proliferation by regulating the FoxO3a transcription factor via SGK1 kinase.
    Mori S; Nada S; Kimura H; Tajima S; Takahashi Y; Kitamura A; Oneyama C; Okada M
    PLoS One; 2014; 9(2):e88891. PubMed ID: 24558442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-dependent protein kinase catalytic subunit (DNA-PKcs)-SIN1 association mediates ultraviolet B (UVB)-induced Akt Ser-473 phosphorylation and skin cell survival.
    Tu Y; Ji C; Yang B; Yang Z; Gu H; Lu CC; Wang R; Su ZL; Chen B; Sun WL; Xia JP; Bi ZG; He L
    Mol Cancer; 2013 Dec; 12(1):172. PubMed ID: 24365180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of mTOR suppresses UVB-induced keratinocyte proliferation and survival.
    Carr TD; DiGiovanni J; Lynch CJ; Shantz LM
    Cancer Prev Res (Phila); 2012 Dec; 5(12):1394-404. PubMed ID: 23129577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photopreventive Effect and Mechanism of AZD4547 and Curcumin C3 Complex on UVB-Induced Epidermal Hyperplasia.
    Khandelwal AR; Rong X; Moore-Medlin T; Ekshyyan O; Abreo F; Gu X; Nathan CA
    Cancer Prev Res (Phila); 2016 Apr; 9(4):296-304. PubMed ID: 26862088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
    Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
    Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IBP-mediated suppression of autophagy promotes growth and metastasis of breast cancer cells via activating mTORC2/Akt/FOXO3a signaling pathway.
    Chen S; Han Q; Wang X; Yang M; Zhang Z; Li P; Chen A; Hu C; Li S
    Cell Death Dis; 2013 Oct; 4(10):e842. PubMed ID: 24113176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The underlying mechanism of proinflammatory NF-κB activation by the mTORC2/Akt/IKKα pathway during skin aging.
    Choi YJ; Moon KM; Chung KW; Jeong JW; Park D; Kim DH; Yu BP; Chung HY
    Oncotarget; 2016 Aug; 7(33):52685-52694. PubMed ID: 27486771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of mTOR complex 2 induces GSK3/FBXW7-dependent degradation of sterol regulatory element-binding protein 1 (SREBP1) and suppresses lipogenesis in cancer cells.
    Li S; Oh YT; Yue P; Khuri FR; Sun SY
    Oncogene; 2016 Feb; 35(5):642-50. PubMed ID: 25893295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA damage-induced S and G2/M cell cycle arrest requires mTORC2-dependent regulation of Chk1.
    Selvarajah J; Elia A; Carroll VA; Moumen A
    Oncotarget; 2015 Jan; 6(1):427-40. PubMed ID: 25460505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
    Shukla S; Rizvi F; Raisuddin S; Kakkar P
    Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional disruption of rictor demonstrates a direct requirement for mTORC2 in skin tumor development and continued growth of established tumors.
    Carr TD; Feehan RP; Hall MN; Rüegg MA; Shantz LM
    Carcinogenesis; 2015 Apr; 36(4):487-97. PubMed ID: 25740823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of 14-3-3 binding to Rictor of mTORC2 for Akt phosphorylation at Ser473 is regulated by selenoprotein W.
    Jeon YH; Park YH; Kwon JH; Lee JH; Kim IY
    Biochim Biophys Acta; 2013 Oct; 1833(10):2135-42. PubMed ID: 23680186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dynamic network model of mTOR signaling reveals TSC-independent mTORC2 regulation.
    Dalle Pezze P; Sonntag AG; Thien A; Prentzell MT; Gödel M; Fischer S; Neumann-Haefelin E; Huber TB; Baumeister R; Shanley DP; Thedieck K
    Sci Signal; 2012 Mar; 5(217):ra25. PubMed ID: 22457331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rictor/mammalian target of rapamycin 2 regulates the development of Notch1 induced murine T-cell acute lymphoblastic leukemia via forkhead box O3.
    Hua C; Guo H; Bu J; Zhou M; Cheng H; He F; Wang J; Wang X; Zhang Y; Wang Q; Zhou J; Cheng T; Xu M; Yuan W
    Exp Hematol; 2014 Dec; 42(12):1031-40.e1-4. PubMed ID: 25201756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forkhead box protein O3 transcription factor negatively regulates autophagy in human cancer cells by inhibiting forkhead box protein O1 expression and cytosolic accumulation.
    Zhu WL; Tong H; Teh JT; Wang M
    PLoS One; 2014; 9(12):e115087. PubMed ID: 25546383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rictor has a pivotal role in maintaining quiescence as well as stemness of leukemia stem cells in MLL-driven leukemia.
    Fang Y; Yang Y; Hua C; Xu S; Zhou M; Guo H; Wang N; Zhao X; Huang L; Yu F; Cheng H; Wang ML; Meng L; Cheng T; Yuan W; Ma D; Zhou J
    Leukemia; 2017 Feb; 31(2):414-422. PubMed ID: 27499138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR.
    Yin Y; Hua H; Li M; Liu S; Kong Q; Shao T; Wang J; Luo Y; Wang Q; Luo T; Jiang Y
    Cell Res; 2016 Jan; 26(1):46-65. PubMed ID: 26584640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.